The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 24, 2020

Filed:

Sep. 08, 2017
Applicant:

Sabila Biosciences Llc, New City, NY (US);

Inventors:

Tarek S. Mansour, New City, NY (US);

Colleen E. Evans, New City, NY (US);

Assignee:

SABILA BIOSCIENCES LLC, New City, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 339/04 (2006.01); C07C 43/29 (2006.01); C07F 5/02 (2006.01); C07F 7/18 (2006.01);
U.S. Cl.
CPC ...
C07D 339/04 (2013.01); C07C 43/29 (2013.01); C07D 487/04 (2013.01); C07F 5/025 (2013.01); C07F 7/1804 (2013.01);
Abstract

This invention provides compounds of the formula (I): wherein Y, Y, Z, X, X, and W' are defined in the specification. These compounds are useful in the treatment of tyrosine kinases, MAPK signaling pathway kinases and PI3K/AKT/mTor signaling pathway kinases-mediated diseases or conditions, such as neurodegeneration, neuroprotection, cancer, autoimmune as well as other diseases and conditions associated with the modulation of tyrosine kinases selected from FYN, FYN Y531F, FLT3, FLT3-ITD, BRK, ITK, FRK, BTK, BMX, SRC, FGR, YES1, LCK, HCK, RET, CSK, LYN, and ROS1; MAPK pathway kinases selected from ARAF, BRAF, CRAF, ERK1/2, MEK1, MEK2, MEK3, MEK4, MEK5, MEK6, and MEK7; and PI3K/AKT/mTor pathway kinases: selected from mTor, PI3K α, PI3K β, PI3K γ, and PI3K δ.


Find Patent Forward Citations

Loading…